Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome

European Journal of Human Genetics

Volumn 22, Issue 11, 2014, Pages 1283-1289

  Bertelsen, Birgitte ^a   Melchior, Linea ^a   Jensen, Lars R ^b   Groth, Camilla ^c   Glenthøj, Birte ^a   Rizzo, Renata ^d   Debes, Nanette Mol ^c   Skov, Liselotte ^c   Brøndum Nielsen, Karen ^a,e   Paschou, Peristera ^f   Silahtaroglu, Asli ^e   Tümer, Zeynep ^a  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF CATANIA   (Italy)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

ADHD; IMMP2L; intronic deletions; OCD; susceptibility gene; Tourette syndrome

Indexed keywords

INNER MITOCHONDRIAL MEMBRANE PEPTIDASE SUBUNIT 2; MESSENGER RNA; PEPTIDASE; UNCLASSIFIED DRUG; IMMP2L PROTEIN, HUMAN; PROTEINASE;

ADULT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBELLUM; CHROMOSOME 7Q; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; EMBRYO; ENZYME SUBUNIT; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC SCREENING; GENETIC TRANSCRIPTION; GILLES DE LA TOURETTE SYNDROME; HIPPOCAMPUS; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; START CODON; ANIMAL; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CAUCASIAN; CHROMOSOME 7; DENMARK; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; GENETICS; MICROARRAY ANALYSIS; OBSESSIVE COMPULSIVE DISORDER; TIC;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 7; DENMARK; DNA COPY NUMBER VARIATIONS; ENDOPEPTIDASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENE DELETION; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MICROARRAY ANALYSIS; OBSESSIVE-COMPULSIVE DISORDER; SEQUENCE ANALYSIS, DNA; TICS; TOURETTE SYNDROME;

EID: 84908513899     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.24     Document Type: Article

References (41)

1. Leckman JF, Bloch MH, Scahill L, King RA: Tourette syndrome: the self under siege. J Child Neurol 2006; 21: 642-649.
2. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P: An international perspective on Tourette syndrome: selected findings from 3, 500 individuals in 22 countries. Dev Med Child Neurol 2000; 42: 436-447.
3. Debes NMM, Hjalgrim H, Skov L: Validation of the presence of comorbidities in a Danish cohort of children with Tourette Syndrome. J Child Neurol 2008; 23: 1017-1027.
4. Clarke RA, Lee S, Eapen V: Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism. Transl Psychiatry 2012; 2: e158.
5. Paschou P: The genetic basis of Gilles de la Tourette Syndrome. Neurosci Biobehav Rev 2013; 37: 1026-1039.
6. Boghosian-Sell L, Comings DE, Overhauser J: Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3. Am J Hum Genet 1996; 59: 999-1005.
7. Petek E, Windpassinger C, Vincent JB et al: Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am J Hum Genet 2001; 68: 848-858.
8. Kroisel PM, Petek E, Emberger W, Windpassinger C, Wladika W, Wagner K: Candidate region for Gilles de la Tourette syndrome at 7q31. Am J Med Genet 2001; 101: 259-261.
9. Díaz-Anzaldúa A, Joober R, Rivière JB et al: Association between 7q31 markers and Tourette syndrome. Am J Med Genet A 2004; 127: 17-20.
10. Petek E, Schwarzbraun T, Noor A et al: Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome. Mol Genet Genomics 2007; 277: 71-81.
11. Patel C, Cooper-Charles L, McMullan DJ, Walker JM, Davison V, Morton J: Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome. Eur J Hum Genet 2011; 19: 634-639.
12. Burri L, Strahm Y, Hawkins CJ et al: Mature DIABLO/Smac is produced by the IMP protease complex on the mitochondrial inner membrane. Mol Biol Cell 2005; 16: 2926-2933.
13. Nunnari J, Fox TD, Walter P: A mitochondrial protease with two catalytic subunits of nonoverlapping specificities. Science 1993; 262: 1997-2004.
14. Gakh O, Cavadini P, Isaya G: Mitochondrial processing peptides. Biochim Biophys Acta 2002; 1592: 63-77.
15. Luo W, Fang H, Green N: Substrate specificity of inner membrane peptidase in yeast mitochondria. Mol Genet Genomics 2006; 275: 431-436.
16. Lu B, Poirier C, Gaspar T et al: A mutation in the inner mitochondrial membrane peptidase 2-like gene (Immp2l) affects mitochondrial function and impairs fertility in mice. Biol Reprod 2008; 78: 601-610.
17. Mattson MP, Gleichmann M, Cheng A: Mitochondria in neuroplasticity and neurological disorders. Neuron 2008; 60: 748-766.
18. Ma Y, Metha SL, Lu B, Li PA: Deficiency in the inner mitochondrial membrane peptidase 2-like (Immp2l) gene increases ischemic brain damage and impairs mitochondrial function. Neurobiol Dis 2011; 44: 270-276.
19. American Psychiatric Association: Diagnostic and Statistical Manual Text Revision (DSM-IV-TR), 4th edn. Washington, DC: American Psychiatric Press, 2000.
20. Silahtaroglu AN, Nolting D, Dyrskjøt L et al: Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protoc 2007; 2: 2520-2528.
21. International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mol Genet 1998; 7: 571-578.
22. Maestrini E, Pagnamenta AT, Lamb JA et al: High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry 2010; 15: 954-968.
23. Elia J, Gai X, Xie HM et al: Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010; 15: 637-646.
24. van Bon BW, Mefford HC, Menten B et al: Further delineation of the 15q31 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009; 46: 511-523.
25. Leblond CS, Heinrich J, Delorme R et al: Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 2012; 8: e1002521.
26. Williams NM, Franke B, Mick E et al: Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry 2012; 169: 195-204.
27. Chilian B, Abdollahpour H, Bierhals T et al: Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin Genet 2013; 84: 560-565.
28. Melchior L, Bertelsen B, Debes NM et al: Microduplication of 15q13.3 and Xq21.31 in a family with tourette syndrome and comorbidities. Am J Med Genet B Neuropsychiatr Genet 2013; 162: 825-831.
29. Menashe I, Larsen EC, Banerjee-Basu S: Prioritization of copy number variation loci associated with autism from AutDB-An integrative multi-study genetics database. PLoS One 2013; 8: e66707.
30. Thomson PA, Malavasi EL, Grünewald E, Soares DC, Borkowska M, Millar JK: DISC1 genetics, biology and psychiatric illness. Front Biol 2013; 8: 1-31.
31. Jacobsen KK, Halmøy A, Sánchez-Mora C et al: DISC1 in adult ADHD patients: an association study in two European samples. Am J Med Genet B 2013; 162: 227-234.
32. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL: Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 2009; 34: 1021-1029.
33. Barateiro A, Vaz AR, Silva SL, Fernandes A, Brites D: ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin. Neuromolecular Med 2012; 14: 285-302.
34. Bohlhalter S, Goldfine A, Matteson S et al: Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain 2006; 129: 2029-2037.
35. Tobe RH, Bansal R, Xu D et al: Cerebellar morphology in Tourette syndrome and obsessive-compulsive disorder. Ann Neurol 2010; 67: 479-487.
36. Thompson VB, Jinnah HA, Hess EJ: Convergent mechanisms in etiologically-diverse dystonia. Brain 2006; 129: 1357-1370.
37. Duenãs AM, Goold R, Giunti P: Molecular pathogenesis of spinocerebellar ataxias. Brain 2006; 129: 1357-1370.
38. Robertson MM: The Gilles de la Tourette syndrome: the current status. Arch Dis Child Educ Pract Ed 2012; 97: 166-175.
39. Tian Y, Liao IH, Zhan X et al: Exon expression and alternatively spliced genes in Tourette Syndrome. Am J Med Genet B 2011; 156: 72-78.
40. Gilbert D: Treatment of children and adolescents with tics and Tourette syndrome. Neurology 2006; 21: 690-700.
41. Katuwawela I, Cavanna AE: Good response to clonidine in tourette syndrome associated with chromosomal translocation involving the IMMP2L gene. J Neuropsychiatry Clin Neurosci 2012; 24: E17.